Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose

Geert V.T. Roozen, Manon L.M. Prins, Corine Prins, Jacqueline J. Janse, Heidi L.M. de Gruyter, Cilia R. Pothast, Wesley Huisman, Jan Pieter R. Koopman, Olivia A.C. Lamers, Marjan Kuijer, Sebenzile K. Myeni, Rob S. van Binnendijk, Gerco den Hartog, Mirjam H.M. Heemskerk, Simon P. Jochems, Mariet C.W. Feltkamp, Marjolein Kikkert, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens

Open source

DOI
10.1016/j.cmi.2024.03.028
Published
2024-07
Container
Clinical Microbiology and Infection
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmi.2024.03.028,
  title = {Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose},
  author = {Geert V.T. Roozen and Manon L.M. Prins and Corine Prins and Jacqueline J. Janse and Heidi L.M. de Gruyter and Cilia R. Pothast and Wesley Huisman and Jan Pieter R. Koopman and Olivia A.C. Lamers and Marjan Kuijer and Sebenzile K. Myeni and Rob S. van Binnendijk and Gerco den Hartog and Mirjam H.M. Heemskerk and Simon P. Jochems and Mariet C.W. Feltkamp and Marjolein Kikkert and Frits R. Rosendaal and Meta Roestenberg and Leo G. Visser and Anna H.E. Roukens},
  year = {2024},
  journal = {Clinical Microbiology and Infection},
  doi = {10.1016/j.cmi.2024.03.028},
  url = {https://doi.org/10.1016/j.cmi.2024.03.028}
}

RIS

TY  - JOUR
TI  - Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose
AU  - Geert V.T. Roozen
AU  - Manon L.M. Prins
AU  - Corine Prins
AU  - Jacqueline J. Janse
AU  - Heidi L.M. de Gruyter
AU  - Cilia R. Pothast
AU  - Wesley Huisman
AU  - Jan Pieter R. Koopman
AU  - Olivia A.C. Lamers
AU  - Marjan Kuijer
AU  - Sebenzile K. Myeni
AU  - Rob S. van Binnendijk
AU  - Gerco den Hartog
AU  - Mirjam H.M. Heemskerk
AU  - Simon P. Jochems
AU  - Mariet C.W. Feltkamp
AU  - Marjolein Kikkert
AU  - Frits R. Rosendaal
AU  - Meta Roestenberg
AU  - Leo G. Visser
AU  - Anna H.E. Roukens
PY  - 2024
JO  - Clinical Microbiology and Infection
DO  - 10.1016/j.cmi.2024.03.028
UR  - https://doi.org/10.1016/j.cmi.2024.03.028
ER  - 

APA

Roozen, G. V., Prins, M. L., Prins, C., Janse, J. J., Gruyter, H. L. D., Pothast, C. R., Huisman, W., Koopman, J. P. R., Lamers, O. A., Kuijer, M., Myeni, S. K., Binnendijk, R. S. V., Hartog, G. D., Heemskerk, M. H., Jochems, S. P., Feltkamp, M. C., Kikkert, M., Rosendaal, F. R., Roestenberg, M., Visser, L. G., & Roukens, A. H. (2024). Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2024.03.028

Source records